Cancer treatment and survivorship statistics, 2025: An urgent call to optimize health after cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed.

1. Synergy in Dual Engagement of Extrinsic and Intrinsic Apoptosis Pathways by Bleomycin and Panobinostat in Hepatocellular Carcinoma and Targeting Mcl-1-Dependent Apoptosis Resistance.Biomedicines · 2026
   Article
2. Impact of unmet needs on health-related quality of life among cancer survivors in Ulsan, Korea.BMC cancer · 2026
   Article
3. Recent advances in nanomaterial-based precision medicine for orthotopic tumor therapy.Journal of nanobiotechnology · 2026
   Review
4. Promoting lifestyle medicine for supportive care in cancer: MASCC endorsement of the ACLM cancer risk reduction and survivorship toolkit.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
   Article
5. Advanced Clinical-Based Technologies for Monitoring Physical Function in Breast Cancer Survivors: Scoping Review.JMIR cancer · 2026
   Article
6. Acupuncture and Acupressure for Cancer Symptom Management: an Opinion Statement Based on Preliminary Evidence Mapping.Current treatment options in oncology · 2026
   Review
7. Epigenetic Reprogramming of Erythroid Progenitor Cells: Insights for Enhancing Cancer Immunotherapy.International journal of biological sciences · 2026
   Review
8. The application of nanotechnology in regulating mitochondrial function in tumor microenvironment for cancer therapy.Theranostics · 2026
   Review
9. TRAIL of Hope: Bioactive Dietary Component-Driven Carrier-Free Nanoplatforms for Synergistically Enhanced Tumor Multimodal Therapy.International journal of nanomedicine · 2026
   Review
10. Survivorship care and cancer survivors' preventive health behaviors by sexual orientation and gender identity.Journal of cancer survivorship : research and practice · 2025
    Article
11. The Ballet of Natural-Product: Carrier-Free "Triadic" Drug Delivery Platforms for Enhanced Tumor Treatment.Journal of functional biomaterials · 2025
    Review
12. Self-reported weight change and diet quality in relation to metabolic syndrome among Korean cancer survivors: a cross-sectional study using the Korea National Health and Nutrition Examination Survey 2019-2021.Korean journal of community nutrition · 2025
    Article
13. Molecular Profiling of Inflammatory and Myofibroblast Cancer-Associated Fibroblast Subtypes Derived from Human Pancreatic Stellate Cells Using Machine Learning-Based Label-Free Raman Spectroscopy.Biomaterials research · 2025
    Article
14. Reporting Quality of Randomized Controlled Trials Published inIntegrative cancer therapies
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as